0

Aminotadalafil

CAS
385769-84-6
Molecular wt
390.39 g/mol
Compound class
β-Carboline-derived Tadalafil analog

Don’t see your product’s COA?

Search our full archive of third-party verified Certificates of Analysis to pull the exact batch you received.

Browse the COA Database

Aminotadalafil

Aminotadalafil is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms and Conditions prior to ordering.

Description

Aminotadalafil Article

Aminotadalafil

Aminotadalafil is a structural analog of tadalafil, modified with an amino functional group on its core chemical scaffold. This precise structural modification alters its physical and chemical properties while maintaining key structural features relevant to phosphodiesterase type 5 (PDE5) research. It serves as a vital tool in laboratory settings for evaluating enzyme binding dynamics, selectivity profiles, and comparative biochemistry.

Technical Specifications

Property Specification
Product Name Aminotadalafil (Amino Tadalafil)
CAS Number 385769-84-6
IUPAC Name (2R,8R)-6-amino-2-(1,3-benzodioxol-5-yl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
Molecular Formula C₂₁H₁₈N₄O₄
Molecular Weight 390.40 g/mol
Chemical Class β-Carboline-derived Tadalafil analog / PDE5 inhibitor analog
Physical Form White to off-white crystalline powder
Solubility Profile Soluble in DMSO (15 mg/mL) and DMF (15 mg/mL); poorly soluble in aqueous buffers
Solution Base PEG-400/DMSO

Core Areas of Research Interest

Aminotadalafil is widely utilized in medicinal chemistry and comparative pharmacology studies. By introducing a primary amine substitution onto the classic tadalafil structure, researchers are able to map out subtle changes in enzyme kinetics and structural tolerance.

Key investigative fields include:

  • Structure-Activity Relationships (SAR): Examining how structural variations in the core scaffold impact binding affinity and comparative molecular footprinting against baseline PDE5 inhibitors.

  • Enzyme Inhibition Kinetics: Studying in vitro binding selectivity, displacement rates, and downstream cyclic guanosine monophosphate (cGMP) stabilization patterns.

  • Metabolic Stability Profiling: Assessing chemical vulnerability to enzymatic breakdown and documenting degradative pathways in closed laboratory systems.

  • Computational Modeling: Serving as a structural reference point to validate predictive docking algorithms and virtual library screenings.

Handling and Laboratory Storage

To protect the structural integrity of the compound during analytical workflows, adhere to standard chemical preservation protocols:

  • Storage Environment: Store in a cool, dry, and dark environment, ideally sealed under inert gas or inside a low-temperature freezer for long-term stabilization.

  • Reconstitution: Dissolve using high-grade, validated organic solvents such as DMSO or DMF before introducing it to experimental buffer assays.

  • Safety Protocols: Utilize standard laboratory personal protective equipment (PPE), including gloves, lab coats, and safety eyewear, during handling and mass measurements.

Related Research Compounds

Further reading: Aminotadalafil research overview

Frequently Asked Questions

How does Aminotadalafil differ structurally from standard Tadalafil?

Aminotadalafil contains a specific primary amine modification on its core scaffold. This substitution alters its baseline electronic properties, molecular weight, and solubility profile while retaining the foundational architecture needed for PDE5 comparative assays.

Is Aminotadalafil approved for therapeutic use?

No. Aminotadalafil is not a licensed pharmaceutical or therapeutic agent. It lacks FDA evaluation or approval and is designated exclusively for laboratory research purposes.

What is the recommended solvent for this compound?

Aminotadalafil demonstrates very poor solubility in water but dissolves readily in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). Solid samples should be completely brought into solution before addition to assay environments.

Analytical Documentation

Purity, identity, and composition vary by manufacturing lot. Kimera Chems does not publish a single fixed purity figure for this item; refer to the batch-specific Certificate of Analysis (COA) issued for the lot received, which reflects third-party analytical testing for that lot. Contact us if a COA for your lot is required.

Research Use Only Disclaimer: This product is synthesized, distributed, and sold strictly as a Research Use Only (RUO) compound intended exclusively for in vitro laboratory evaluation and analytical testing. Kimera Chems does not supply this compound for human consumption, veterinary use, or any form of clinical therapeutic applications.

Compound Class β-Carboline-derived Tadalafil analog
CAS Number 385769-84-6
Other Names Tadalafil N-Desmethyl N-Amino Impurity, RR-ATDF, AS-79374, DA-70773
IUPAC Name (2R,8R)-6-amino-2-(1,3-benzodioxol-5-yl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
Molecular Formula C₂₁H₁₈N₄O₄
Molecular Weight 390.39 g/mol
Capsule Concentration 5mg x 60ct; 20mg x 60ct
Liquid Concentration And Solution 20mg/ml PEG400, DMSO
Bulk Powder Quantity 1g


Kimerachems
By starting a chat with our artificial intelligence-powered assistant, you agree to the automated processing of your personal data.
Kimera Chems assistant
...